CGM Subsidy News: What Changed for Australians in 2026
MSAC backed CGM subsidy access for type 3c diabetes but deferred type 2 diabetes. Here’s what it means for you.
-
-
ADA 2026 Diabetes Guidelines: What’s New and What It Means
The ADA’s 2026 Standards of Care bring big changes to CGM, insulin pumps and medicines. Here’s what it means for Australians.
-
RACGP Diabetes Guidelines 2026: What’s Changing for GPs
Australian GPs are using updated diabetes guidance in 2026, with earlier heart- and kidney-protective medicines and new advice for CGM and youth type 2 diabetes.
-
GLP-1 Access in Australia: New Delivery Model Sparks Debate
Home delivery for Mounjaro, PBS updates for Ozempic and Wegovy, and what’s changing for people with diabetes seeking GLP-1 medicines.
